Novavax (NVAX) News Today $8.70 +0.02 (+0.23%) (As of 12/20/2024 05:51 PM ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Wellington Management Group LLP Acquires New Holdings in Novavax, Inc. (NASDAQ:NVAX)Wellington Management Group LLP bought a new position in Novavax, Inc. (NASDAQ:NVAX - Free Report) in the third quarter, according to the company in its most recent disclosure with the SEC. The fund bought 73,115 shares of the biopharmaceutical company's stock, valued at approximately $923,000. A nDecember 20 at 3:39 AM | marketbeat.comNovavax (NASDAQ:NVAX) Stock Quotes, Forecast and News SummaryDecember 19 at 8:14 AM | benzinga.comNovavax says Australia cancels delivery of some Covid-19 dosesDecember 18 at 5:56 PM | tipranks.comNovavax, Inc. (NASDAQ:NVAX) Shares Acquired by Barclays PLCBarclays PLC boosted its stake in Novavax, Inc. (NASDAQ:NVAX - Free Report) by 73.9% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 709,579 shares of the biopharmaceutical company's stock afteDecember 18 at 4:07 AM | marketbeat.comHead-To-Head Review: Novavax (NASDAQ:NVAX) versus Sutro Biopharma (NASDAQ:STRO)December 18 at 2:09 AM | americanbankingnews.comState Street Corp Purchases 1,621,772 Shares of Novavax, Inc. (NASDAQ:NVAX)State Street Corp lifted its holdings in Novavax, Inc. (NASDAQ:NVAX - Free Report) by 26.7% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 7,687,951 shares of the biopharmaceutical company's stock afteDecember 17, 2024 | marketbeat.comUnusually active option classes on open December 16thDecember 16, 2024 | tipranks.comTidal Investments LLC Has $6.32 Million Stake in Novavax, Inc. (NASDAQ:NVAX)Tidal Investments LLC reduced its position in shares of Novavax, Inc. (NASDAQ:NVAX - Free Report) by 21.1% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 500,000 shares of the biopharmaceutical company's stock afterDecember 14, 2024 | marketbeat.comNovavax Nabs $50M From First Sanofi Partnership Milestone: Retail Optimism ClimbsDecember 13, 2024 | msn.comNovavax Advances Corporate Growth Strategy Through Sanofi Partnership, Including Achievement of First $50 Million MilestoneDecember 13, 2024 | prnewswire.comNovavax Inc. stock rises Wednesday, still underperforms marketDecember 12, 2024 | marketwatch.comInstitutional investors control 53% of Novavax, Inc. (NASDAQ:NVAX) and were rewarded last week after stock increased 6.3%December 12, 2024 | finance.yahoo.comNovavax Gains Buy Rating Amid Vaccine Development Advancements and Strong Valuation ModelDecember 11, 2024 | markets.businessinsider.comJim Cramer Is 'Not A Fan' Of Novavax, Says This Tech Stock Is 'Expensive'December 10, 2024 | benzinga.comNovavax begins dosing in COVID-19-influence and season influenza Phase 3 trialDecember 10, 2024 | tipranks.comNovavax Initiates Phase 3 Trial for COVID-19-Influenza Combination and Stand-Alone InfluenzaDecember 10, 2024 | prnewswire.comNovavax call volume above normal and directionally bullishDecember 9, 2024 | tipranks.comTwo Sigma Advisers LP Has $25.25 Million Stake in Novavax, Inc. (NASDAQ:NVAX)Two Sigma Advisers LP grew its position in Novavax, Inc. (NASDAQ:NVAX - Free Report) by 48.9% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 1,999,400 shares of the biopharmaceutical company's stock after acquiring an aDecember 8, 2024 | marketbeat.comBNP Paribas Financial Markets Cuts Stock Holdings in Novavax, Inc. (NASDAQ:NVAX)BNP Paribas Financial Markets reduced its stake in Novavax, Inc. (NASDAQ:NVAX - Free Report) by 59.3% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 143,156 shares of the biopharmaceutical cDecember 8, 2024 | marketbeat.comNovavax, Inc. (NASDAQ:NVAX) Shares Purchased by Charles Schwab Investment Management Inc.Charles Schwab Investment Management Inc. boosted its position in shares of Novavax, Inc. (NASDAQ:NVAX - Free Report) by 16.5% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,325,508 shares of the biopharmaceDecember 8, 2024 | marketbeat.comNovavax (NASDAQ:NVAX) Trading Up 10.1% - Time to Buy?Novavax (NASDAQ:NVAX) Stock Price Up 10.1% - Should You Buy?December 6, 2024 | marketbeat.comStock Traders Purchase High Volume of Call Options on Novavax (NASDAQ:NVAX)Novavax, Inc. (NASDAQ:NVAX - Get Free Report) saw some unusual options trading activity on Friday. Traders acquired 26,350 call options on the stock. This represents an increase of approximately 25% compared to the typical volume of 21,001 call options.December 6, 2024 | marketbeat.comNovavax call volume above normal and directionally bullishDecember 6, 2024 | tipranks.comZacks Research Brokers Reduce Earnings Estimates for NovavaxNovavax, Inc. (NASDAQ:NVAX - Free Report) - Zacks Research reduced their FY2024 earnings per share estimates for Novavax in a note issued to investors on Tuesday, December 3rd. Zacks Research analyst S. Ganoria now anticipates that the biopharmaceutical company will post earnings per share of ($1December 6, 2024 | marketbeat.comNovavax Inc. stock remains steady Thursday, still outperforms marketDecember 6, 2024 | marketwatch.com2 Beaten-Down "Pandemic Stocks" to Consider for Contrarian InvestorsDecember 5, 2024 | fool.comWegovy Maker Novo Nordisk To Buy Novavax's Czech Republic Manufacturing Facility For $200 MillionDecember 4, 2024 | benzinga.comNovavax Stock Rises, Boosts Retail Sentiment On $200M Czech Plant Sale To Novo NordiskDecember 4, 2024 | msn.comNovavax to sell Czech manufacturing unit to Novo Nordisk for $200 millionDecember 4, 2024 | msn.comNovavax to sell Czech Republic manufacturing facility to Novo Nordisk for $200MDecember 4, 2024 | tipranks.comEdgestream Partners L.P. Makes New Investment in Novavax, Inc. (NASDAQ:NVAX)Edgestream Partners L.P. bought a new stake in Novavax, Inc. (NASDAQ:NVAX - Free Report) during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The fund bought 125,114 shares of the biopharmaceutical company's stock, valued at approximately $1,580,000. EdgestreDecember 4, 2024 | marketbeat.comNovavax To Sell Manufacturing Facility In Bohumil, Czech Republic To Novo Nordisk For $200 MlnDecember 4, 2024 | markets.businessinsider.comNovavax to sell Czech manufacturing unit to Novo Nordisk for $200 mlnDecember 4, 2024 | reuters.comNovavax Announces Sale of Czech Republic Manufacturing Site to Novo Nordisk for $200 MillionDecember 4, 2024 | prnewswire.comConnor Clark & Lunn Investment Management Ltd. Sells 97,515 Shares of Novavax, Inc. (NASDAQ:NVAX)Connor Clark & Lunn Investment Management Ltd. lessened its position in shares of Novavax, Inc. (NASDAQ:NVAX - Free Report) by 68.8% in the third quarter, according to its most recent filing with the SEC. The firm owned 44,260 shares of the biopharmaceutical company's stock after selling 97,515 shaNovember 30, 2024 | marketbeat.comBank of Montreal Can Purchases 517,727 Shares of Novavax, Inc. (NASDAQ:NVAX)Bank of Montreal Can increased its position in Novavax, Inc. (NASDAQ:NVAX - Free Report) by 26.7% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,454,325 shares of the biopharmaceuticNovember 29, 2024 | marketbeat.comNovavax, Inc. (NASDAQ:NVAX) Receives Average Rating of "Hold" from AnalystsNovavax, Inc. (NASDAQ:NVAX - Get Free Report) has earned an average recommendation of "Hold" from the six brokerages that are covering the stock, Marketbeat reports. One equities research analyst has rated the stock with a sell recommendation, two have assigned a hold recommendation and three havNovember 29, 2024 | marketbeat.comNovavax to Present at Jefferies London ConferenceNovember 21, 2024 | markets.businessinsider.comIs Biotech’s Bull Run Over? Examining Election Impacts (NVAX)The biotech sector's breakout attempt post-election reversed sharply, with ETFs like IBB and XBI falling and invalidating the long-term bullish setup.November 21, 2024 | marketbeat.comNovavax, Inc. (NVAX) Jefferies London Healthcare Conference (Transcript)November 20, 2024 | seekingalpha.comWhat is B. Riley's Forecast for Novavax FY2024 Earnings?Novavax, Inc. (NASDAQ:NVAX - Free Report) - Investment analysts at B. Riley reduced their FY2024 EPS estimates for shares of Novavax in a research report issued to clients and investors on Monday, November 18th. B. Riley analyst M. Mamtani now anticipates that the biopharmaceutical company will pNovember 20, 2024 | marketbeat.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Novavax, Inc. - NVAXNovember 18, 2024 | prnewswire.comStrategic Transformation and Growth Prospects: Mayank Mamtani’s Buy Rating on NovavaxNovember 18, 2024 | markets.businessinsider.comFY2024 Earnings Estimate for Novavax Issued By HC WainwrightNovavax, Inc. (NASDAQ:NVAX - Free Report) - HC Wainwright lowered their FY2024 earnings per share (EPS) estimates for Novavax in a research report issued on Wednesday, November 13th. HC Wainwright analyst V. Bernardino now expects that the biopharmaceutical company will earn ($1.29) per share forNovember 18, 2024 | marketbeat.comNovavax, Inc. (NASDAQ:NVAX) Just Reported Earnings, And Analysts Cut Their Target PriceNovember 16, 2024 | finance.yahoo.comNovavax Inc. stock underperforms Friday when compared to competitors despite daily gainsNovember 16, 2024 | marketwatch.comNovavax Announces Grant of Inducement Awards Pursuant to Nasdaq Listing Rule 5635(c)(4)November 15, 2024 | prnewswire.comBiotech Stock Roundup: NVAX Q3 Results, SNDX Down on AML Data, RNA Surges on Study DataNovember 14, 2024 | finance.yahoo.comNovavax Inc (NVAX) Q3 2024 Earnings Call Highlights: Strategic Partnerships and Financial ...November 14, 2024 | finance.yahoo.comNovavax: Balancing Potential and Risk Amid Strategic Shifts and Uncertain Market OutlookNovember 14, 2024 | markets.businessinsider.com Get Novavax News Delivered to You Automatically Sign up to receive the latest news and ratings for NVAX and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Humiliated: Demo of Elon’s Tech Proves They’re Wrong (Ad)Elon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is not buying it. Click here to watch this demo and decide for yourself. NVAX Media Mentions By Week NVAX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NVAX News Sentiment▼0.870.61▲Average Medical News Sentiment NVAX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NVAX Articles This Week▼710▲NVAX Articles Average Week Get Novavax News Delivered to You Automatically Sign up to receive the latest news and ratings for NVAX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Alkermes News Amicus Therapeutics News Ligand Pharmaceuticals News Geron News Celldex Therapeutics News MannKind News Dynavax Technologies News BioCryst Pharmaceuticals News Myriad Genetics News Innoviva News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:NVAX) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredWhat most folks don’t know about oil (BIG missed opportunity)$1 Trillion… That’s how much Big Tech is set to spend on AI investment in the coming months—according to Go...ProsperityPub | SponsoredHas Trump Finally Gone Too Far?Lately, there's been a lot of buzz around a secret loophole executive insiders are using to make millions buyi...Insiders Exposed | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | Sponsored2025 AI Stock Picks: 2 Hidden Gems Under $10/ShareThe AI sector continues to make waves as we move into 2025, and now is a prime opportunity to get involved—wit...Darwin | SponsoredWe recommended Palantir in 2021, now we’re recommending this...My research indicates there is only one investment that can meet AI's unprecedented demand for energy.Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Novavax, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Novavax With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
